SIGLEC1 and neoplasm: Our study demonstrated that CD204+ and CD169+ Mφ subpopulations display tissue-specific distributions and distinct composition patterns in different tissue micro-localizations, and have diverse prognostic values during tumor progression in HCC and GC.